2SEVENTY BIO, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.8 USD | -4.19% |
|
+9.59% | +12.41% |
| May. 08 | Earnings Flash (TSVT) 2SEVENTY BIO Reports Q1 Revenue $12.4M, vs. Street Est of $14.1M | MT |
| May. 08 | Transcript : 2seventy bio, Inc., Q1 2024 Earnings Call, May 08, 2024 |
Chart calendar 2seventy bio, Inc.
7a2e7f58698e556379f6422.1sVBwyG6xT_u9TG9a1BTo9OSyQflb1k_crM5PuqPxoE.pJcyq1XDh1vXknXeXDk31LbguWSDARsIIORPZNP1oMqgoweMWdeGcdmQQg~d210e3e44b1e9752414b2c5728944861
Upcoming events on 2seventy bio, Inc.
Past events on 2seventy bio, Inc.
| 2024-05-08 08:00 am | Q1 2024 Earnings Call |
| 2024-05-08 07:00 am | Q1 2024 Earnings Release |
| 2024-03-14 | Oncologic Drugs Advisory Committee Meeting |
| 2024-03-13 08:00 am | Leerink Partners Global Biopharma Conference |
| 2024-03-06 02:10 pm | TD Cowen Health Care Conference |
| 2024-03-05 08:00 am | Q4 2023 Earnings Call |
| 2024-03-05 07:00 am | Q4 2023 Earnings Release |
| 2024-02-22 03:00 pm | Citi Oncology Leadership Summit |
| 2024-02-08 01:30 pm | Guggenheim Healthcare Talks Biotechnology Conference |
| 2024-01-30 08:00 am | Business Update Call |
| 2023-12-12 08:00 am | American Society of Hematology Meeting |
| 2023-12-11 07:45 pm | American Society of Hematology Meeting |
| 2023-12-09 08:30 pm | American Society of Hematology Meeting |
| 2023-11-14 08:00 am | Q3 2023 Earnings Call |
| 2023-11-14 07:00 am | Q3 2023 Earnings Release |
| 2023-09-13 03:35 pm | Morgan Stanley Global Healthcare Conference |
| 2023-09-12 08:00 am | Business Update Call |
| 2023-08-14 08:00 am | Q2 2023 Earnings Call |
| 2023-08-14 07:00 am | Q2 2023 Earnings Release |
| 2023-08-08 08:00 am | Wedbush PacGrow Healthcare Conference |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 54,5 55,2 -1.25% | 91,5 49,8 83.56% | 100 106 -5.23% | 49,1 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | -298 -308 3.49% | -252 -276 8.93% | -227 -226 -0.79% | -164 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -314 -334 5.89% | -263 -298 11.63% | -238 -228 -4% | -158 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -292 -335 12.83% | -254 -297 14.39% | -218 -209 -3.98% | -161 |
|
Net income Million USD | Released Forecast Spread | -120 | -292 -322 9.24% | -254 -291 12.77% | -218 -216 -0.5% | -162 |
|
EPS USD | Released Forecast Spread | -5,00 | -12,4 -10,6 -17.69% | -7,13 -8,33 14.43% | -4,42 -4,36 -1.43% | -2,97 |
| Announcement Date | 08/10/21 | 22/03/22 | 16/03/23 | 05/03/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 8,43 22,7 -62.8% | 13,5 16,5 -18.38% | 13,4 12,4 8.43% | 56,2 15,3 267.82% | 41,6 22,3 86.61% | 36,0 36,9 -2.23% | 12,0 31,2 -61.4% | 10,7 15,2 -29.64% | 12,4 14,1 -11.72% | 11,8 | 11,1 | 12,3 | 12,6 | 13,2 |
|
EBITDA Million USD | Released Forecast Spread | -45,8 -59,6 23.24% | -56,9 -50,4 -12.92% | -49,0 -37,3 -31.53% | -43,9 | -38,4 | -36,5 | ||||||||
|
EBIT Million USD | Released Forecast Spread | -90,6 -71,4 -26.9% | -77,0 -78,0 1.34% | -68,4 -72,2 5.33% | -27,2 -67,1 59.47% | -51,7 -63,2 18.23% | -48,0 -48,9 1.86% | -57,3 -50,0 -14.49% | -59,9 -50,8 -18.01% | -51,2 -47,3 -8.23% | -40,3 | -35,4 | -31,4 | ||
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -85,7 -69,3 -23.67% | -77,4 -70,8 -9.36% | -67,9 -75,0 9.45% | -23,1 -65,9 64.86% | -47,0 -60,1 21.79% | -42,1 -50,0 15.77% | -71,6 -57,4 -24.73% | -56,8 -48,5 -17.16% | -52,7 -44,9 -17.31% | -38,5 | -37,1 | -33,9 | ||
|
Net income Million USD | Released Forecast Spread | -85,7 -52,0 -64.96% | -77,4 -72,7 -6.54% | -67,9 -70,8 4.16% | -23,1 -59,8 61.33% | -47,0 -57,9 18.76% | -42,1 -51,2 17.8% | -71,6 -58,7 -22.1% | -56,8 -55,7 -1.94% | -52,7 -41,0 -28.48% | -38,5 | -37,1 | -33,9 | ||
|
EPS USD | Released Forecast Spread | -3,20 -1,82 -76.15% | -2,02 -1,93 -4.66% | -1,76 -1,85 4.99% | -0,60 -1,56 61.48% | -1,08 -1,27 14.96% | -0,83 -1,07 22.43% | -1,40 -1,15 -21.48% | -1,11 -1,05 -5.97% | -1,01 -0,81 -24.36% | -0,74 | -0,65 | -0,56 | -0,24 | -0,23 |
| Announcement Date | 12/05/22 | 10/08/22 | 07/11/22 | 16/03/23 | 03/05/23 | 14/08/23 | 14/11/23 | 05/03/24 | 08/05/24 | - | - | - | - | - |
| 2024-05-20 | ALVOTECH: Q1 2024 Earnings Release |
| 2024-05-21 07:00 am | EXSCIENTIA PLC: Q1 2024 Earnings Release |
| 2024-05-21 | CUREVAC N.V.: Q1 2024 Earnings Release (Projected) |
| 2024-05-21 | EVOTEC SE: Q1 2024 Earnings Release |
| 2024-06-30 | IMMUNOVANT, INC.: Q4 2024 Earnings Release (Projected) |
| 2024-07-15 01:45 am | ADDLIFE AB: Q2 2024 Earnings Release |
| 2024-07-21 | MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release (Projected) |
| 2024-07-23 | SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release (Projected) |
| 2024-07-23 | ALKERMES PLC: Q2 2024 Earnings Release (Projected) |
| 2024-07-23 | IQVIA HOLDINGS INC.: Q2 2024 Earnings Release (Projected) |
Past sector events for 2seventy bio, Inc.
| 2024-05-17 02:00 am | BIOARCTIC AB: Q1 2024 Earnings Release |
| 2024-05-15 04:05 pm | CULLINAN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-14 | GNI GROUP LTD.: Q1 2024 Earnings Release |
| 2024-05-14 04:05 pm | NUVATION BIO INC.: Q1 2024 Earnings Release |
| 2024-05-14 07:30 am | ABSCI CORPORATION: Q1 2024 Earnings Release |
| 2024-05-14 01:50 am | BELITE BIO, INC: Q1 2024 Earnings Release |
| 2024-05-13 | POLARIS GROUP: Q1 2024 Earnings Release |
| 2024-05-13 04:30 pm | AEROVATE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-13 07:00 am | APOGEE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-12 07:00 pm | PRAXIS PRECISION MEDICINES, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- TSVT Stock
- Calendar 2seventy bio, Inc.
